Michael R. Apostol
banner
mapostol.bsky.social
Michael R. Apostol
@mapostol.bsky.social
Neuroscience PhD student at UCLA | Research interests: brain stimulation, neuroimaging, substance use & mood disorders

www.michaelapostol.com
Recently, the US Justice Department and President Trump cut funding to UCLA, threatening medical breakthroughs that provide lifesaving treatments. Science improves health, drives innovation, and strengthens our economy.

#StandUpForUC #ResearchPowersProgress

mapostol.medium.com/the-cost-of-...
The Cost of Defunding Biomedical Research at UCLA
A PhD Student’s Perspective on Funding Cuts to Neuroscience
mapostol.medium.com
August 19, 2025 at 11:58 PM
Happy to share new results: we compared accelerated 5x5 rTMS (5 treatments per day for 5 days) vs conventional six week rTMS. Both protocols were effective in treating depression, and 5x5 patients who displayed limited initial response improved significantly ~4 weeks after rTMS.
August 19, 2025 at 11:54 PM
We are seeking participants in Los Angeles, California aged 18-65 who use cannabis and tobacco regularly. Join our study to explore the effects of Transcranial Magnetic Stimulation (TMS) on reducing cannabis and tobacco use. Free TMS treatment & up to $450 compensation.
August 11, 2025 at 7:20 PM
Reposted by Michael R. Apostol
When assessing the impact of rTMS on cigarette craving and withdrawal, which target do you think produces the best outcomes - dorsolateral PFC, superior frontal gyrus, or posterior parietal cortex?

Find out in this new NPP paper from Peterson & team

www.nature.com/artic...
Comparing neuromodulation targets to reduce cigarette craving and withdrawal: a randomized clinical trial
Neuropsychopharmacology - Comparing neuromodulation targets to reduce cigarette craving and withdrawal: a randomized clinical trial
www.nature.com
May 15, 2025 at 4:30 PM
Reposted by Michael R. Apostol
How can we individualize non-invasive brain stimulation protocols to improve treatment outcomes?

This review article highlights 4 potential opportunities, including context, target, dose, and timing

www.nature.com/artic...
Four dimensions of individualization in brain stimulation for psychiatric disorders: context, target, dose, and timing
Neuropsychopharmacology - Four dimensions of individualization in brain stimulation for psychiatric disorders: context, target, dose, and timing
www.nature.com
April 23, 2025 at 3:31 PM